David Ettinger

Medicine & Life Sciences

1. Non-Small Cell Lung Carcinoma 100%
2. Small Cell Lung Carcinoma 86%
3. Drug Therapy 60%
4. Radiotherapy 35%
5. Lung Neoplasms 33%
6. Neoplasms 32%
7. Survival 31%
8. Paclitaxel 31%
9. Cisplatin 28%
10. Therapeutics 28%
11. Practice Guidelines 26%
12. Radiation Oncology 25%
13. Guidelines 22%
14. Etoposide 20%
15. Carboplatin 18%
16. Appointments and Schedules 16%
17. Sarcoma 16%
18. Vomiting 14%
19. Breast Neoplasms 14%
20. gemcitabine 14%
21. Lung 13%
22. Ifosfamide 13%
23. Cyclophosphamide 13%
24. Doxorubicin 13%
25. Topotecan 13%
26. Antiemetics 13%
27. Carcinoembryonic Antigen 12%
28. Biomarkers 12%
29. Pharmaceutical Preparations 11%
30. Radiation 10%
31. methylformamide 10%
32. Nausea 10%
33. Immunotherapy 10%
34. Methotrexate 9%
35. Combination Drug Therapy 9%
36. Thorax 9%
37. Adjuvant Chemotherapy 9%
38. Pemetrexed 9%
39. Liver 8%
40. Carcinoma 8%
41. Early Detection of Cancer 8%
42. Neoplasm Metastasis 8%
43. Maximum Tolerated Dose 8%
44. ErbB Receptors 8%
45. Pharmacokinetics 8%
46. Ovarian Neoplasms 8%
47. Antibodies 8%
48. Survival Rate 8%
49. Leukopenia 7%
50. Thymoma 7%